Cardium Therapeutics, Inc. (CXM) Swings to Q4 Loss
Tweet
Share
E-mailGet Alerts CXM Hot Sheet
Price: $5.33 -5.16%
EPS Growth %: -8.3%
Financial Fact:
Total operating expenses: 1.19M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -8.3%
Financial Fact:
Total operating expenses: 1.19M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Cardium Therapeutics, Inc. (AMEX: CXM) reported Q4 EPS of ($0.02), versus $0.01 reported last year.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
